We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
AxoGen (AXGN) Shows Strength: Stock Adds 6.1% in Session
Read MoreHide Full Article
AxoGen, Inc. (AXGN - Free Report) was a big mover last session, as the company saw its shares rise a little above 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Also, this led to far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 26% in the past one-month time frame.
The company has seen two negative estimate revisions in the past 30 days. Also, its Zacks Consensus Estimate moved lower over the same timeframe. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
AxoGen currently has a Zacks Rank #4(Sell), while its Earnings ESP is a negative.
Is AXGN going up? Or down? Predict to see what others think: Up or Down
Zacks' 2017 IPO Watch List
Before looking into the stocks mentioned above, you may want to get a head start on potential tech IPOs that are popping up on Zacks' radar. Imagine being in the first wave of investors to jump on a company with almost unlimited growth potential? This Special Report gives you the current scoop on 5 that may go public at any time.
One has driven from 0 to a $68 billion valuation in 8 years. Four others are a little less obvious but already show jaw-dropping growth. Download this IPO Watch List today for free >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
AxoGen (AXGN) Shows Strength: Stock Adds 6.1% in Session
AxoGen, Inc. (AXGN - Free Report) was a big mover last session, as the company saw its shares rise a little above 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Also, this led to far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 26% in the past one-month time frame.
The company has seen two negative estimate revisions in the past 30 days. Also, its Zacks Consensus Estimate moved lower over the same timeframe. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
AxoGen currently has a Zacks Rank #4(Sell), while its Earnings ESP is a negative.
AxoGen, Inc. Price
AxoGen, Inc. Price | AxoGen, Inc. Quote
A top-ranked stock in the Medical – Generic Drugs industry is Corium International, Inc. sporting a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Is AXGN going up? Or down? Predict to see what others think: Up or Down
Zacks' 2017 IPO Watch List
Before looking into the stocks mentioned above, you may want to get a head start on potential tech IPOs that are popping up on Zacks' radar. Imagine being in the first wave of investors to jump on a company with almost unlimited growth potential? This Special Report gives you the current scoop on 5 that may go public at any time.
One has driven from 0 to a $68 billion valuation in 8 years. Four others are a little less obvious but already show jaw-dropping growth. Download this IPO Watch List today for free >>